This 2011 review by Teff and Kim explores how atypical antipsychotics (AAPs) influence central and peripheral mechanisms regulating appetite and metabolism. AAPs, notably clozapine and olanzapine, are associated with significant weight gain and metabolic disturbances. The authors discuss how these drugs affect hypothalamic pathways, particularly through antagonism of histamine H1
